InvestorsHub Logo
Followers 7
Posts 1303
Boards Moderated 0
Alias Born 03/08/2019

Re: None

Thursday, 02/10/2022 10:02:38 AM

Thursday, February 10, 2022 10:02:38 AM

Post# of 3433
181 per cent upside to Auxly Cannabis, says Research Capital

“We view the streamlining of cultivation assets to be positive mainly due to three reasons,” Velagapudi said. “Firstly, this enables the company to turn relatively asset light. Secondly, the potential proceeds from the sale will boost the capital position. Thirdly, the cost savings from lower operating expenses will improve profitability.”

https://www.cantechletter.com/2022/02/181-per-cent-upside-to-auxly-cannabis-says-research-capital/#

Glad to hear Auxly is implementing automation in pre-rolls, which are labor intensive when handmade manually. If the first Reddit reviews are any indication Kolab's Live Terpene Sicks are a big hit with lots of likes. Infused pre-rolls are a major category in mature US markets, and just getting started Canada. To me the price target is way too low, and underestimates cannabis 2.0 market share. Believe 2022 will be a great year for concentrates!!! Fingers Crossed :) glta

Kolab Project - 232 Series Live Terpene Sticks - 27.9% THC

https://www.reddit.com/r/TheOCS/comments/sivw1i/kolab_project_232_series_live_terpene_sticks_279/

Posts are my opinion only, and not advice of any kind. glta